hdr isap 2019

News March 2015

Best known for his contribution to the development of PK/PD principles, Dr. William A. Craig has passed away Wednesday March 11, 2015. Dr. Craig was an extraordinary man and a shining star in the fields of infectious diseases and antimicrobial therapy. His passing leaves a large void in our lives and field.
Obituary (D. Andes)

News November 2014

Polymyxin consensus has been published in Lancet Infectious Diseases

The results of the Polymyxin conference in Prato, Italy, May 2013 have been published in Lancet Infectious Diseases:

RL Nation, J Li, O. Cars, W. Couet, MN Dudley, KS Kaye, JW Mouton, DL Paterson, VH Tam, U. Theuretzbacher, BT Tsuji, JD Turnidge: Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus

Continue Reading

News May 2014

ISAP publication - Bedside dosing!
Lancet Infect Dis April 2014

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Jason A Roberts, Mohd H Abdul-Aziz, Jeff rey Lipman, Johan W Mouton, Alexander A Vinks, Timothy W Felton, William W Hope, Andras Farkas, Michael N Neely, Jerome J Schentag, George Drusano, Otto R Frey, Ursula Theuretzbacher, Joseph L Kuti, on behalf of The International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious Diseases

ISAP and EPASG recently published this review on individualised dosing for critically ill patients. In this review, we explore the challenges related to patients and pathogens that contribute to inadequate antibiotic dosing and discuss how to implement a process for individualised antibiotic therapy that increases the accuracy of dosing and optimises care for critically ill patients.

Please sign in and read the full paper.

News October 2014

Conference on Reviving Old Antibiotics in Vienna great success!

Almost 300 researchers, academics and representatives from pharmaceutical companies and national medical agencies convened in Vienna for the three day conference entitled ‘Reviving Old Antibiotics’. They reviewed the increasing threat of AMR, and explored the potential benefits and disadvantages of using old, off-patent antibiotics that may still be effective against some pathogens resistant to more modern treatments, with a view to creating an action plan for taking this initiative forward.
More here...

News April 2014

Opportunity for Young Investigator!

The Department of Clinical Pharmacology, one of the largest departments in Europe in its field and dedicated to clinical research, is seeking a young expert in PK and/or PK/PD modelling for building a Vienna modelling research group.

Antimicrobial agents will be one major focus of this group within the department; however, Vienna Research Group leaders are to be independent in designing their research work and recruiting their staff. WWTF (funding organisation for research projects of the city of Vienna) in total grants up to 1.6 Mio. € per research group for six to eight years. Full proposal have to be submitted by 24 July 2014 by the research institution.

More information can be found here or by contacting Markus Zeitlinger (markus zeitlinger(at)meduniwien.ac.at)